Condition: Prostatic Neoplasms · Sponsor: Janssen Research & Development, LLC
The purpose of this study is to determine if treatment with apalutamide plus androgen deprivation therapy (ADT) before and after radical prostatectomy (RP) with pelvic lymph node dissection (pLND) in participants with high-risk localized or locally advanced prostate cancer results in an improvement in pathological complete response (pCR) rate and metastasis-free survival (MFS) as compared to placebo plus ADT.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| UC San Diego Moores Cancer Center | La Jolla, California, United States | — |
| University of Southern California | Los Angeles, California, United States | — |
| Cedars Sinai Medical Center | Los Angeles, California, United States | — |
| University of California Los Angeles | Los Angeles, California, United States | — |
| University of California Irvine Medical Center Chao Family Comprehensive Cancer Center | Orange, California, United States | — |
| UC Davis Medical Center | Sacramento, California, United States | — |
| AdventHealth Medical Group Urology of Denver | Denver, Colorado, United States | — |
| Colorado Clinical Research | Lakewood, Colorado, United States | — |
| Stamford Hospital | Stamford, Connecticut, United States | — |
| Urology Specialists LLC | Hialeah, Florida, United States | — |
| Mayo Clinic - Division Of Hematology/oncology | Jacksonville, Florida, United States | — |
| Miami Cancer Institute at Baptist Health / Baptist Health Medical Group | Miami, Florida, United States | — |
+ 191 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.